Yearly Archives: 2021
BioUtah Submits Comments on Proposed MCIT Repeal
VIA ELECTRONIC SUBMISSION October 15, 2021 The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-3372-P2 P.O. Box 8013 Baltimore, MD 21244–8013 Re: Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary” Proposed Rule: [CMS-3372-P2] Dear Administrator Brooks-LaSure: BioUtah appreciates the […]
BioUtah Kicks-Off the 2021 Virtual BioHive Summit with Dr. Dean Li, President, Merck Research Laboratories
The BioHive Summit, powered in partnership with BioUtah, on Nov. 12 will live stream a distinguished line-up of speakers and panelists from inside and outside Utah’s burgeoning life sciences industry.
New WTC Utah Grants for Doing Business in the Middle East
Join WTC Utah in Dubai, UAE for the largest U.S. government-led trade mission and business development forum.
Certus Critical Care Awarded Two Department of Defense Grants for Development of Endovascular Device
Grants Totaling Over $3M Earmarked for Life Saving Medical Technology to Combat Massive Blood Loss
MPF II NEXT Makes its Debut Investment in iVeena Delivery Systems
A clinical stage ophthalmology company, iVeena is developing disease-modifying therapeutics for a rare corneal disorder and an increasingly common form of nearsightedness
Utah Rep. Blake Moore Tours Logan’s BioHive Community
Yesterday, US Rep. Blake Moore (R-UT-1) visited the burgeoning BioHive community in Logan, touring Utah State University’s (USU0 state-of-the-art BioInnovations Center, Quansys Biosciences and ELITech. Utah’s life sciences industry, from Logan to St. George, is one of the fastest-growing in the nation. “Cache Valley has become a hub for bioscience, and I thank BioUtah for […]
PolarityTE Provides Update on Investigational New Drug Application
SALT LAKE CITY, Oct. 7, 2021 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided an update regarding its Investigational New Drug Application (IND) for SkinTE® with a proposed indication for chronic cutaneous ulcers submitted to the Food and Drug Administration (FDA) in July 2021. The Company received […]
Renalytix Launching KidneyIntelX in Veterans Health Administration Hospitals
NEW YORK and SALT LAKE CITY, Oct. 07, 2021 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the expansion of its commercial strategy to address early-stage kidney disease in the Veterans Health Administration patient population with the appointment of Jed Fulk to the position of Vice President Sales, Government Accounts. Mr. Fulk […]
Stryker: Patient impact: our inspiration
Stryker CEO, Kevin Lobo, recently shared his thoughts about his work at Stryker and what it means to help make a difference for patients
BioHive Names Katelin Roberts Executive Director
BioHive, Utah’s collective of life sciences and healthcare innovation companies, today announced that Katelin Roberts will serve as the full time Executive Director, effective immediately.
Recursion is Granted Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
Recursion announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for REC-4881 for the potential treatment of familial adenomatous polyposis (FAP).
NIH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS
SINTX Technologies, Inc., an original equipment manufacturer of advanced ceramics, announced today a Phase 1 grant of $308,301 awarded by the National Institute of Health (NIH) to develop a 3-D printed, composite silicon nitride – polyetheretherketone (SN-PEEK) spinal implant.
